Skip to main content
. Author manuscript; available in PMC: 2014 May 28.
Published in final edited form as: J Neurooncol. 2009 May 9;93(1):61–77. doi: 10.1007/s11060-009-9867-7

Table 1.

Clinical criteria for definition of hearing response based on a 50-word hearing test

Baseline word
recognition
score (%)
95% critical
difference (%)
Hearing
response (%)
Progressive
disease (%)
0 0–4 ≥6 n/a
2 0–10 ≥12 n/a
4 0–14 ≥16 n/a
6 2–18 ≥20 0
8 2–22 ≥24 0
10 2–24 ≥26 0
12 4–26 ≥28 ≤2
14 4–30 ≥32 ≤2
16 6–32 ≥34 ≤4
18 6–34 ≥36 ≤4
20 8–36 ≥38 ≤6
22 8–40 ≥42 ≤6
24 10–42 ≥44 ≤8
26 12–44 ≥46 ≤10
28 14–46 ≥48 ≤12
30 14–48 ≥50 ≤12
32 16–50 ≥52 ≤14
34 18–52 ≥54 ≤16
36 20–54 ≥56 ≤18
38 22–56 ≥58 ≤20
40 22–58 ≥60 ≤20
42 24–60 ≥62 ≤22
44 26–62 ≥64 ≤24
46 28–64 ≥66 ≤26
48 30–66 ≥68 ≤28
50 32–68 ≥70 ≤30
52 34–70 ≥72 ≤32
54 36–72 ≥74 ≤34
56 38–74 ≥76 ≤36
58 40–76 ≥78 ≤38
60 42–78 ≥80 ≤40
62 44–78 ≥80 ≤42
64 46–80 ≥82 ≤44
66 48–82 ≥84 ≤46
68 50–84 ≥86 ≤48
70 52–86 ≥88 ≤50
72 54–86 ≥88 ≤52
74 56–88 ≥90 ≤54
76 58–90 ≥92 ≤56
78 60–92 ≥94 ≤58
80 64–92 ≥94 ≤62
82 66–94 ≥96 ≤64
84 68–94 ≥96 ≤66
86 70–96 ≥98 ≤68
88 74–96 ≥98 ≤72
90 76–98 100 ≤74
92 78–98 100 ≤76
94 82–98 100 ≤80
96 86–100 n/a ≤84
98 90–100 n/a ≤88
100 96–100 n/a ≤94

Upper and lower limits for the 95% critical differences for percentage scores (second column). Changes in word recognition within the 95% critical difference are not statistically different from the baseline score. In use, third (for improved hearing) or fourth (for decreased hearing) columns are compared to baseline scores in first column. Adapted from Thornton and Raffin [147]